HLA-A*1101 & B2M & HPV16-E6 (TTLEQQYNK) Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Mavrilimumab | CAM-3001; KPL-301; GM-CSFR; CAM3001 | Phase 3 Clinical | Csl Ltd | Pneumonia; Giant Cell Arteritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19) | Details |
| CSF2RA gene-corrected macrophages(University of South Florida) | Phase 2 Clinical | Russian Academy Of Medical Sciences | Pulmonary Alveolar Proteinosis | Details | |
| STSA-1005 | STSA-1005; STSA1005 | Phase 1 Clinical | Coronavirus Disease 2019 (COVID-19) | Details |